ReviewNeurocase2013
Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.
Review in Neurocase, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- The Central Nervous System Modulatory Activities of N-Acetylcysteine: A Synthesis of Two Decades of Evidence.Current issues in molecular biology · 2025Review
- Systems-Level Interactome Mapping Reveals Actionable Protein Network Dysregulation Across the Alzheimer's Disease Spectrum.Research square · 2025Article
- The Association of Dietary Inflammatory Index and Cognitive Function in Iranian Elders.Recent advances in food, nutrition & agriculture · 2024Article
- Microbiome Alterations and Alzheimer's Disease: Modeling Strategies with Transgenic Mice.Biomedicines · 2023Review
- Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.Acta pharmaceutica Sinica. B · 2022Review
- A Sedentary and Unhealthy Lifestyle Fuels Chronic Disease Progression by Changing Interstitial Cell Behaviour: A Network Analysis.Frontiers in physiology · 2022Article
- Altered immune phenotype and DNA methylation in panic disorder.Clinical epigenetics · 2020Article
- Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice.Acta pharmaceutica Sinica. B · 2020Article
- Exploiting Common Aspects of Obesity and Alzheimer's Disease.Frontiers in human neuroscience · 2020Review
- Blueberries Improve Neuroinflammation and Cognition differentially Depending on Individual Cognitive baseline Status.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019Article
- A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.EMBO molecular medicine · 2018Article
- Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study.European journal of nutrition · 2017Observational
- SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.Human molecular genetics · 2017Article
- Youthful Processing Speed in Older Adults: Genetic, Biological, and Behavioral Predictors of Cognitive Processing Speed Trajectories in Aging.Frontiers in aging neuroscience · 2017Article
- MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes.Alzheimer's & dementia (Amsterdam, Netherlands) · 2016Article
- Neuroprotective effect of paeoniflorin on HExperimental and therapeutic medicine · 2015Article
- Declines in inflammation predict greater white matter microstructure in older adults.Neurobiology of aging · 2015Article
- Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Molecular neurobiology · 2014Review
- Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.Journal of neuroinflammation · 2014Article
- Frontotemporal dementia: diagnosis, deficits and management.Neurodegenerative disease management · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
A proposed immune mechanism that potentially modifies or exacerbates neurodegenerative disease presentation in older adults has received considerable attention in the past decade, with recent studies demonstrating a strong link between pro-inflammatory markers and neurodegeneration. The overarching aim of the following review is to synthesize recent research that supports a possible relationship between inflammation and clinical features of neurodegenerative diseases, including risk of development, cognitive and clinical correlates, and progression of the specified diseases. Specific emphasis is placed on providing a temporal context for the association between inflammation and neurodegeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.